Adverse drug reactions in breastfed infants: Less than imagined

Clinical Pediatrics

Volumn 42, Issue 4, 2003, Pages 325-340

  Anderson, Philip O ^a,b   Pochop, Stacey L ^c   Manoguerra, Anthony S ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Tri City Medical Center   (United States)

^d California Poison Control System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CHLORPROMAZINE; CITALOPRAM; FLUOXETINE; GASTROINTESTINAL AGENT; HYDROCODONE BITARTRATE PLUS PARACETAMOL; IODIDE; LITHIUM; NEFAZODONE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PERCOCET; PETHIDINE; PHENOBARBITAL; PRIMIDONE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNINDEXED DRUG;

ABDOMINAL CRAMP; AGRANULOCYTOSIS; APNEA; ARTICLE; BLEEDING; BRADYCARDIA; BREAST FEEDING; BREAST HYPERPLASIA; BREAST MILK; CHOLESTASIS; COLIC; CYANOSIS; DIARRHEA; DROWSINESS; DRUG MILK LEVEL; DYSPHORIA; FACE EDEMA; FEEDING DISORDER; FOLIC ACID DEFICIENCY; GLUCOSURIA; HEARING DISORDER; HEMATURIA; HEMOLYTIC ANEMIA; HERXHEIMER REACTION; HUMAN; HYPERACTIVITY; HYPERGLYCEMIA; HYPOTENSION; HYPOTHERMIA; HYPOTHYROIDISM; INFANT; INFANT MORTALITY; IRRITABILITY; JAUNDICE; LETHARGY; LIVER TOXICITY; MACROCYTIC ANEMIA; MAJOR CLINICAL STUDY; METABOLIC ACIDOSIS; MYOCLONUS; NEUTROPENIA; NEWBORN; PSEUDOMEMBRANOUS COLITIS; PYLORUS STENOSIS; RASH; RESPIRATION DEPRESSION; RESTLESSNESS; SEIZURE; SIDE EFFECT; SKIN DISEASE; SLEEP DISORDER; SOMNOLENCE; SUDDEN INFANT DEATH SYNDROME; TACHYPNEA; THROMBOCYTOPENIC PURPURA; TOXIC HEPATITIS; VOMITING;

EID: 0041846574     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280304200405     Document Type: Article

References (153)

1. Ito S, Lieu M, Chan W, Koren G. Continuing drug therapy while breastfeeding. Part 1. Common misconceptions of patients. Can Fam Physician. 1999;45:897-899.
2. Lee A, Chen WN, Koren G, Ito S. Physicians' advice as an influential factor on the decision to breasffeed in a cohort of women on carbamazepine. Pediatr Res. 2000;47:472A.
3. Scialli A. Drugs and lactation - another failure of product labeling. Reprod Toxicol. 1996;10:91-92.
4. Lawrence RA, McCooey AJM, Friedman LR. A comparison of the recommendations for management of breasffeeding in the face of maternal antihypertensives and antidepressants in six well-known references. J Toxicol Clin Toxicol. 2000;38:566.
5. Food and Drug Administration. Concept paper on pregnancy labeling. Summary of comments from a public hearing and model pregnancy labeling based on recommendations. 1999:1-16.
6. Anon. Infant Rx exposure level from breast milk may serve as a threshold for trials. FDC Rep. 2001;63:29.
7. Anon. Lactation section of labeling could add risk of discontinuing breastfeeding. FDC Rep. 2000;62:12-13.
8. Ito S, Blajchman A, Stephenson M, et al. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 1993;168:1393-1399.
9. Bennett PN, ed. Drugs and Human Lactation, 2nd ed. Amsterdam: Elsevier; 1996.
10. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, 6th ed. Baltimore: Williams & Wilkins; 2002.
11. Hale T. Medications and Mothers' Milk, 8th ed. Amarillo: Pharmasoft Medical Publishing; 1999.
12. Anderson PO. Drugs and breastfeeding. In: Anderson PO, Knoben JE, Troutman WG, eds. Handbook of Clinical Drug Data, 10th ed. New York: McGraw-Hill; 2002.
13. Burt VK, Suri R, Altshuler L, et al. The use of psychotropic medications during breast-feeding. Am J Psychiatry. 2001;158:1001-1009.
14. Newport DJ, Wilcox MM, Stowe ZN. Antidepressants during pregnancy and lactation: defining exposure and treatment issues. Semin Perinatol. 2001;25:177-190.
15. American Academy of Pediatrics. Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108:776-789.
16. Fomina PI. Untersuchungen über den übergang des ajtiven agens des mutterkorns in die milch stillender mütter. Arch Gynakol. 1934;157:275-285.
17. Lauritzen C. On endocrine effects of oral contraceptives. Acta Endocrinol. 1967:87-100.
18. Havelka J, Franková A. Príspevek k vedlejsím úcinkum chloramfenikolu u novorozencu. Cesk Pediatr. 1972;27:31-33.
19. Föllmer W. Über die anwendung sulfonamiden im wochenbett. Klin Wochnschr. 1941;20:912-913.
20. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
21. Martens PR. A sudden infant death like syndrome possibly induced by a benzodiazepine in breast-feeding. Eur J Emerg Med. 1994;1:86-87.
22. Juul S. Fenemalforgiftning via modermaelken? Ugeskr Laeg. 1969;131:2257-2258.
23. Smialek JE, Monforte JR, Aronow R, et al. Methadone deaths in children: a continuing problem. JAMA. 1977;238:2516-2517.
24. Pardthaisong T, Yenchit C, Gray R. The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation. Contraception. 1992;45:313-324.
25. Abdel-Aleem H, Abol-Oyoun E-SM, Shaaban MM, et al. The use of nomegestrol acetate subdermal contraceptive implant, Uniplant, during lactation. Contraception. 1996;54:281-286.
26. Casteels K, Pünt S, Brämswig J. Transient neonatal hypothyroidism during breastfeeding after post-natal maternal topical iodine treatment. Eur J Pediatr. 2000;159:716-717.
27. Danziger Y, Pertzelan A, Mimouni M. Transient congenital hypothyroidism after topical iodine in pregnancy and lactation. Arch Dis Child. 1987;62:295-296.
28. Delange F, Chanoine JP, Abrassart C, Bourdoux P. Topical iodine, breast-feeding, and neonatal hypothyroidism. Arch Dis Child. 1988;63:106-107.
29. Rakover YE, Hajdu SI. Thyroid function disturbances in an infant following maternal topical use of Polydine. Harefuah. 1989;116:527-529.
30. Arena Ansotegui J, Emparanza Knörr JI, San Millan Vege MJ, et al. Sobrecarga iodada al recién nacido por utilizar PVP-iodada para la preparación perineal materna en el parto vaginal. An Esp Pediatr. 1989;30:23-26.
31. Chanoine JP, Abrassart C, Bourdoux P, et al. Surcharge iodée et hypothyroïdie transitoire chez le nouveau-né. Rev Med Brux. 1988;9:48-55.
32. Chanoine JP, Boulvain M, Bourdoux P, et al. Increased recall rate at screening for congenital hypothyroidism in breast fed infants born to iodine overloaded mothers. Arch Dis Child. 1988;63:1207-1210.
33. Koga Y, Sano H, Kikukawa Y, et al. Affect on neonatal thyroid function of povidone-iodine used on mothers during perinatal period. J Obstet Gynecol. 1995;21:581-585.
34. Chanoine JP, Pardou A, Bourdoux P, Delange F. Withdrawal of iodinated disinfectants at delivery decreases the recall rate at neonatal screening for congenital hypothyroidism. Arch Dis Child. 1988;63:1297-1298.
35. Plomp TA, Vulsma T, de Vijlder JJM. Use of amiodarone during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1992;43:201-207.
36. Marriq P, Oddo G. La gynecomastie induite chez le nouveau-ne par le lait maternel? Un accident rare des contraceptifs oraux. Nouv Presse Med. 1974;3:2579.
37. Kora SJ. Effect of oral contraceptives on lactation. Fertil Steril. 1969;20:419-423.
38. Croxatto HB, Díaz S, Peralta O, et al. Fertility regulation in nursing women: IV. Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth. Contraception. 1983;27:13-25.
39. Díaz S, Peralta O, Juez G, et al. Fertility regulation in nursing women: III. Short-term influence of a low-dose combined oral contraceptive upon lactation and infant growth. Contraception. 1983;27:1-11.
40. Peralta O, Díaz S, Juez G, et al. Fertility regulation in nursing women: V. Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum on lactation and infant growth. Contraception. 1983;27:27-39.
41. Shaaban M, Abol-Oyoun M, Yousef AE, et al. Progestogen-only contraceptives during lactation: I. Infant growth. Contraception. 1994;50:35-53.
42. Bassol S, Nava-Hernandez MP, Hernandez-Morales C, et al. Effects of levonorgestrel implant upon TSH and LH levels in male infants during lactation. Int J Gynecol Obstet. 2002;76:273-277.
43. Laukaran VH. The effects of contraceptive use on the initiation and duration of lactation. Int J Gynaecol Obstet. 1987;25(suppl):129-142.
44. World Health Organization Task Force for Epidemiological Research on Reproductive Health. Progestogen-only contraceptives during lactation: I. Infant growth. Contraception. 1994;50:35-53.
45. World Health Organization Task Force for Epidemiological Research on Reproductive Health, Special Programme of Research, Development and Research Training in Human Reproduction. Progestogen-only contraceptives during lactation: II. Infant development. Contraception. 1994;50:55-68.
46. Baheiraei A, Ardsetani N, Ghazizadeh S. Effects of progestogen-only contraceptives on breast-feeding and infant growth. Int J Gynecol Obstet. 2001;74:203-205.
47. Díaz S. Contraceptive implants and lactation. Contraception. 2002;65:39-46.
48. Hannon PR, Duggan AK, Serwint JR, et al. The influence of medroxyprogesterone on the duration of breast-feeding in mothers in an urban community. Arch Pediatr Adolesc Med. 1997;151:490-496.
49. Davis JM, Bhutani VK. Neonatal apnea and maternal codeine use. Pediatr Res. 1985;19 (4, pt. 2):170A.
50. Wittels B, Glosten B, Faure EAM, et al. Postcesarean analgesia with both epidural morphine and intravenous patient-controlled analgesia: neurobehavioral outcomes among nursing neonates. Anesth Analg. 1997;85:600-606.
51. Wittels B, Scott DT, Sinatra RS. Exogenous opioids in human breast milk and acute neonatal neurobehavior: a preliminary study. Anesthesiology. 1990;73:864-869.
52. Naumburg EG, Meny RG. Breast milk opioids and neonatal apnea. Am J Dis Child. 1988;142:11-12.
53. Anderson PO. Medication use while breast feeding a neonate. Neonatal Pharmacol Q. 1993;2:3-14.
54. Granström M-L, Bardy AH, Hiilesmaa VK. Prolonged feeding difficulties of infants of primidone mothers during neonatal period: preliminary results from the Helsinki study. In: Janz D, et al., eds. Epilepsy, Pregnancy and the Child. New York: Raven Press; 1982:357-358.
55. Kaneko S, Suzuki K, Sato T, et al. The problems of antiepileptic medication in the neonatal period: is breast-feeding advisable? In: Janz D, Dam M, Richens A, et al. Epilepsy, Pregnancy and the Child. New York: Raven Press; 1982:343-348.
56. Kuhnz W, Koch S, Helge H, Nau H. Primidone and phenobarbital during lactation period in epileptic women: total and free drug serum levels in the nursed infants and their effects on neonatal behavoir. Dev Pharmacol Ther. 1988;11:147-154.
57. Tyson RM, Shrader EA, Perlman HH. Drugs transmitted through breast milk, II: Barbituates. J Pediatr 1938;14:86-90.
58. Kuhnz W, Koch S, Jacob S, et al. Ethosuximide in epileptic women during pregnancy and lactation period. Placental transfer, serum concentration in nursed infants. Br J Clin Pharmacol. 1984;18:671-677.
59. Göpfert-Geyer I, Koch S, Rating D, et al. Delivery, gestation, data at birth, and neonatal period in children of epileptic mothers. In: Janz D, Bossi L, Dam M, et al., eds. Epilepsy, Pregnancy and the Child. New York: Raven Press; 1982:179-187.
60. Frey B, Schubiger G, Musy JP. Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding. Eur J Pediatr. 1990;150:136-138.
61. Froescher W, Eichelbaum M, Niesen M, et al. Carbamazepine levels in breast milk. Ther Drug Monit. 1984;6:266-271.
62. Kuhnz W, Jager-Roman E, Rating D, et al. Carbamazepine and carbamazepine 10,11-epoxide during pregnancy and postnatal period in epileptic mothers and their nursed infants and their effects on neonatal behavior. Pediatr Pharmacol. 1983;3:199-208.
63. Stahl MMS, Neiderud J, Vinge E. Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. J Pediatr. 1997;130:1001-1003.
64. Finch E, Lorber J. Methaemoglobinaemia in the newborn. Probably due to phenytoin excreted in human milk. J Obstet Gynaecol Br Emp. 1954;61:833-834.
65. Merlob P, Mor N, Litwin A. Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breast feeding. Ann Pharmacother. 1992;26:1563-1565.
66. Frey B BCGD. Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding. Ann Pharmacother. 2002;36:644-647.
67. Matheson I, Pande H, Alertsen AR. Respiratory depression caused by N-desmethyldoxepin in breast milk. Lancet. 1985;2:1124.
68. Frey OR, Scheidt P, von Brenndorff AI. Adverse effects in a newborn infant breast-fed by a mother treated with doxepin. Ann Pharmacother. 1999;33:690-693.
69. Buist A, Janson H. Effect of exposure to dothiepin and northiaden in breast milk on child development. Br J Psychiatry. 1995;167:370-373.
70. Yoshida K, Smith B, Craggs M, Kumar RC. Investigation of pharmacokinetics and possible adverse effects in infants exposed to tricyclic anti-depressants in breast-milk. J Affective Disord. 1997;43:225-237.
71. Isenberg KE. Excretion of fluoxetine in human breast milk. J Clin Psychiatry. 1990;51:169.
72. Kristensen JH, Ilett KF, Hackett LP, et al. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol. 1999;48:521-527.
73. Lester BM, Cucca J, Andreozzi L, et al. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry. 1993;32:1253-1255.
74. Rohan A. Drug distribution in human milk. Aust Prescriber. 1997;20:84
75. Hale TW, Shum S, Grossberg M. Fluoxetine toxicity in a breastfed infant. Clin Pediatr. 2001;40:681-684.
76. Brent NB, Wisner KL. Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr 1998;37:41-44.
77. Yoshida K, Smith B, Craggs M, Channi Kumar R. Fluoxetine in breast-milk and developmental outcome of breast-fed infants. Br J Psychiatry. 1998;172:175-179.
78. Chambers CD, Anderson PO, Thomas RG, et al. Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics. 1999;104:e61.
79. Moretti ME, Sharma A, Bar-Oz B, et al. Fluoxetine and its effects on the nursing infant: a prospective cohort. Clin Pharmacol Ther. 1999;65:141.
80. Schmidt K, Oleson OV, Jensen PN. Citalopram and breast-feeding: serum concentration and side effects in the infant. Biol Psychiatry. 2000;47:164-165.
81. Mammen OK, Perel JM, Rudolph G, et al. Sertraline and norsertraline levels in three breastfed infants. J Clin Psychiatry. 1997;58:100-103.
82. Epperson N, Czarkowski KA, Ward-O'Brien D, et al. Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am J Psychiatry. 2001;158:1631-1637.
83. Hendrick NT, Fukuchi A, Altshuler L, et al. Use of sertraline, paroxetine and fluvoxamine by nursing women. Br J Psychiatry. 2001;179:163-166.
84. Dodd S, Stock A, Buist A, et al. Sertraline in paired blood plasma and breast-milk samples from nursing mothers. Hum Psychopharmacol Clin Exp. 2000;15:261-264.
85. Yapp P, Ilett KF, Kristensen JH, et al. Drowsiness and poor feeding in a breast-fed infant: association with nefazodone and its metabolites. Ann Pharmacother. 2000;34:1269-1272.
86. Lacey JH. Dichloralphenazone and breast milk. Br Med J. 1971;4:684.
87. Wiles DH, Orr MW, Kolakowska T. Chlorpromazine levels in plasma and milk of nursing mothers. Br J Clin Pharmacol. 1978;5:272-273.
88. Yoshida K, Smith B, Craggs M, Kumar R. Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants. Psychol Med. 1998;28:81-91.
89. Dev VJ, Krupp P. Adverse event profile and safety of clozapine. Rey Contemp Pharmacother. 1995;6:197-208.
90. Anderson PO, McGuire GG. Neonatal alprazolam withdrawal - possible effects of breast feeding. DICP. 1989;23:614.
91. Wesson DR, Camber S, Harkey M, Smith DE. Diazepam and desmethyldiazepam in breast milk. J Psychoactive Drugs. 1985;17:55-56.
92. Patrick MJ, Tilstone WJ, Reavey P. Diazepam and breast-feeding. Lancet. 1972;1:542-543.
93. Fisher JB, Edgren BE, Mammel MC, Coleman JM. Neonatal apnea associated with maternal clonazepam therapy: a case report. Obstet Gynecol. 1985;66(suppl):34S-35S.
94. Woody JN, London WL, Wilbanks GD Jr. Lithium toxicity in a newborn. Pediatrics. 1971;47:94-96.
95. Tunnessen WW Jr, Hertz CG. Toxic effects of lithium in newborn infants: a commentary. J Pediatr. 1972;81:804-807.
96. Austin M-PV, Mitchell PB. Use of psychotropic medications in breast-feeding women: acute and prophylactic treatment. Aust N Z J Psychiatry. 1998;32:778-784.
97. Stowe ZN, Strader JR, Nemeroff CB. Psychopharmacology during pregnancy and lactation. In: Schatzberg AF, Nemroff CB, eds. Essetials of Clinical Psychopharmacology. Washington, DC: American Psychiatric Press. 2001:659-680.
98. Craig M AK. Prescribing for psychiatric disorders in pregnancy and lactation. Best Pract Res Clin Obstet Gynaecol. 2001;15:1013-1030.
99. Ito S. Drug therapy for breast-feeding women. N Engl J Med. 2000;343:118-126.
100. Iqbal MM, Gundlapalli SP, Ryan WG, et al. Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants. South Med J. 2001;94:304-322.
101. Boutroy MJ, Bianchetti G, Dubruc C, et al. To nurse when receiving acebutolol: is it dangerous for the neonate? Eur J Clin Pharmacol. 1986;30:737-739.
102. Schimmel MS, Eidelman AI, Wilschanski MA, et al. Toxic effects of atenolol consumed during breast feeding. J Pediatr. 1989;114:476-478.
103. Ho TK, Moretti ME, Schaeffer JK, et al. Maternal β-blocker usage and breast feeding in the neonate. Pediatr Res. 1999;45:67A.
104. Clark JH, Wilson WG. A 16-day-old breast-fed infant with metabolic acidosis caused by salicylate. Clin Pediatr. 1981;20:53-54.
105. Terragna A, Spirito L. Porpora trombocitopenica in lattante dopo somministrazione di acido acetilsalicilico alla nutrice. [Thrombocytopenic purpura in an infant after administration of acetylsalicilic acid to the wet-nurse.]. Minerva Pediatr. 1967;19:613-616.
106. Harley JD, Robin H. "Late" neonatal jaundice in infants with glucose-6-phosphate dehydrogenase-deficient erythrocytes. Aust Ann Med. 1962;11:148-155.
107. Fidalgo I, Correa R, Gomez Carrasco JA, Martinez Quiroga F. Anemia aguda, rectorragia y hematuria asociadas a la ingestion de naproxen. An Esp Pediatr 1989;30:317-319.
108. Lebedevs TH, Wojnar-Horton RE, Yapp P, et al. Excretion of indomethacin in breast milk. Br J Clin Pharmacol. 1991;32:751-754.
109. Beaulac-Baillargeon L, Allard G. Distribution of indomethacin in human milk and estimation of its milk to plasma ratio in vitro. Br J Clin Pharmacol. 1993;36:413-416.
110. Walter K, Dilger C. Ibuprofen in human milk. Br J Clin Pharmacol. 1997;44:211-212.
111. Sanders SW, Zone JJ, Foltz RL, et al. Hemolytic anemia induced by dapsone transmitted through breast milk. Ann Intern Med. 1982;96:465-466.
112. Laffont A, Bonafos M. Influence sur l'enfant de la sulfamidothérapie maternelle. Gynecol Obstet. 1942;45:447-459.
113. Belton EM, Jones RV. Haemolytic anaemia due to nalidixic acid. Lancet. 1965;2:691.
114. Branski D, Kerem E, Gross-Kieselstein E, et al, Bloody diarrhea - a possible complication of sulfasalazine transferred through human breast milk. J Pediatr Gastroenterol Nutr. 1986;5:316-317.
115. Williams M. Excretion of drugs in milk. Pharm J. 1976;217:219.
116. Harmon T, Burkhart G, Applebaum H. Perforated pseudomembranous colitis in the breast-fed infant. J Pediatr Surg. 1992;27:744-746.
117. Mann CF. Clindamycin and breastfeeding. Pediatrics. 1980;66:1030-1031.
118. Clements Cj. Metronidazole and breast feeding. NZ Med J. 1980;92:329.
119. Campbell AC, Mc Elnay JC, Passmore CM. The excretion of ampicillin in breast milk and its effect on the suckling infant. Br J Clin Pharmacol. 1991;31:230p.
120. Browne SG, Hogerzeil LM. "B 663" in the treatment of leprosy: preliminary report of a pilot trial. Lepr Rev. 1962;33:6-10.
121. Waters MFR. G 30 320 or B 663 - Lampren (Geigy). A working party held at the Royal Garden Hotel London, September 1968. Lepr Rev. 1969;40:21-47.
122. Fåhraeus R. On the sulfathiazole treatment of puerperal infections. Gynaecologia. 1947;123:386-395.
123. Rollier R, Rollier M, Bellouchi M. Réaction d'Herxheimer au lait maternal dans une syphilis congénitale précoce. Bull Soc Dermatol Syphil. 1967;74:178-180.
124. Greenhalf JO, Leonard HSD. Laxatives in the treatment of constipation in pregnant and breast-feeding mothers. Practitioner. 1973;210:259-263.
125. Nelis GF. Diarrhoea due to 5-aminosalicylic acid in breast milk. Lancet. 1989;1:383.
126. Moretti ME, Spiczynski Y, Hashemi G, et al. Prospective follow-up of infants exposed to 5-aminosalicylic acid containing drugs through maternal milk. J Clin Pharmacol. 1998;38:867.
127. Kok THHG, Taitz LS, Bennett MJ, Holt DW. Drowsiness due to clemastine transmitted in breast milk. Lancet. 1982;1:914-915.
128. Mortimer EA Jr. Drug toxicity from breast milk? Pediatrics. 1977;60:780-781.
129. Anderson PO. Decongestants and milk production. J Hum. Lact. 2000;16:294.
130. Amato D, Niblett JS. Neutropenia from cyclophosphamide in breast milk. Med J Aust. 1977;1:383-384.
131. Durodola JI. Administration of cyclophosphamide during late pregnancy and early lactation: a case report. J Nat Med Assoc. 1979;71:165-166.
132. Matheson I, Lunde PKM, Notarianni L. Infant rash caused by paracetamol in breast milk? Pediatrics. 1985;76:651-652.
133. Bell RAF, Dale IM. Gold secretion in maternal milk. Arthritis Rheum. 1976;19:1374.
134. Van Der Bogert F. Bromin poisoning through mother's milk. Am J Dis Child. 1921;21:167-169.
135. Tyson RM, Shrader EA, Perlman HH. Drugs transmitted through breast milk. III. Bromides. J Pediatr 1938;14:91-93.
136. Stier BJ, Sieverding L, Moeller H. Pentoxyverin-intoxikation uber die muttermilch bei einem vollgetillten neugeborenen. Dtsch Med Wochenschr. 1988;113:898-900.
137. Madhavapeddi R, Ramachandran P. Side effects of oral contraceptive use in lactating women - enlargement of breast in a breast-fed child. Contraception. 1985;32:437-443.
138. Nilsson S, Nygren K-G, Johansson EDB. Ethinyl estradiol in human milk and plasma after oral administration. Contraception. 1978;17:131-139.
139. Nilsson S, Nygren K-G, Johansson EDB. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women. Am J Obstet Gynecol. 1977;129:178-184.
140. Curtis EM. Oral-contraceptive feminization of a normal male infant. Obstet Gynecol. 1964;23:295-296.
141. Mandel H, Berant M. Oral contraceptives and breastfeeding: haematological effects on the infant. Arch Dis Child. 1985;60:971-980.
142. Rizzoni G, Furlanut M. Cyanotic crisis in a breast-fed infant from mother taking dipyrone. Human Toxicol. 1984;3:505-507.
143. Stang H. Pyloric stenosis associated with erythromycin ingested through breast milk. Min Med. 1986;69:669-670, 682.
144. Ball DE, Morrison P. Oestrogen transdermal patches for post partum depression in lactating mothers - a case report. Central Afr J Med. 1999;45:68-70.
145. Eeg-Olofsson O, Malmros I, Elwin C-E, Steen B. Convulsions in a breast-fed infant after maternal indomethacin. Lancet. 1978;2:215.
146. Skausig OB, Schou M. Diegivning under lithiumbehandling. Ugeskr Laeg. 1977;139:400-401.
147. Schou M. Lithium treatment during pregnancy, delivery, and lactation: an update. J Clin Psychiatry. 1990;51:410-413.
148. Lownes HE, Ives TJ. Mexiletine use in pregnancy and lactation. Am J Obstet Gynecol. 1987;157:446-447.
149. Fraser D, Turner JWA. Myasthenia gravis and pregnancy. Proc R Soc Med. 1963;56:379-381.
150. Eckstein HB, Jack B. Breast-feeding and anticoagulant therapy. Lancet. 1970;1:672-673.
151. Frei H, Bühlman U, Rudin O. Toxische hämolytische anämie beim neugeborenen nach ingestion eines phenazon-derivates (Cibalgin) via muttermilch. Z Geburtshilfe Perinatol. 1985;189:11-12.
152. Harley JD, Robin H. "Late" neonatal jaundice following maternal treatment with sulfamethoxypyridazine. Pediatrics. 1966;37:855-856.
153. Yurchak AM, Jusko WJ. Theophylline secretion into breast milk. Pediatrics. 1976;57:518-525.